Bovine glycomacropeptide is anti-inflammatory in rats with hapten-induced colitis

Journal of Nutrition

Volumn 135, Issue 5, 2005, Pages 1164-1170

  Daddaoua, Abdelali ^a   Puerta, Víctor ^a   Zarzuelo, Antonio ^a   Suárez, María D ^a   Sánchez De Medina, Fermín ^a   Martínez Augustin, Olga ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Casein macropeptide; Glycomacropeptide; Inflammatory bowel disease; Trinitrobenzenesulfonic acid

Indexed keywords

ALKALINE PHOSPHATASE; GLYCOPROTEIN; HAPTEN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; MESSENGER RNA; SALAZOSULFAPYRIDINE; TREFOIL PEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; COLITIS; COLON INJURY; DOSE RESPONSE; ENTERITIS; ENZYME ACTIVITY; FEMALE; IMMUNOCOMPETENT CELL; NONHUMAN; RAT; WEIGHT REDUCTION;

BACTERIA (MICROORGANISMS); BOVINAE; LOTUS;

EID: 18344394842     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.5.1164     Document Type: Article

References (44)

1. Brody, E. P. (2000) Biological activities of bovine glycomacropeptide. Br. J. Nutr. 84: S39-S46.
2. Bruck, W. M., Kelleher, S. L., Gibson, G. R., Nielsen, K. E., Chatterton, D.E.W. & Lönnerdal, B. (2003) rRNA probes used to quantify the effects of glycomacropeptide and alpha-lactalbumin supplementation on the predominant groups of intestinal bacteria of infant rhesus monkeys challenged with enteropathogenic Escherichia coli. J. Pediatr. Gastroenterol. Nutr. 37: 273-280.
3. Bruck, W. M., Graverholt, G. & Gibson, G. R. (2003) A two-stage continuous culture system to study the effect of supplemental alpha-lactalbumin and glycomacropeptide on mixed cultures of human gut bacteria challenged with enteropathogenic Escherichia coli and Salmonella serotype typhimurium. J. Appl. Microbiol. 95: 44-53.
4. Li, E.W.Y. & Mine, Y. (2004) Immunoenhancing effects of bovine glycomacropeptide and its derivatives on the proliferative response and phagocytic activities of human macrophagelike cells, U937. J. Agric. Food Chem. 52: 2704-2708.
5. Otani, H., Monnai, M., Kawasaki, Y., Kawakami, H. & Tanimoto, M. (1995) Inhibition of mitogen-induced proliferative responses of lymphocytes by bovine kappa-caseinoglycopeptides having different carbohydrate chains. J. Dairy Res. 62: 349-357.
6. Monnai, M., Horimoto, Y. & Otani, H. (1998) Immunomodificatory effect of dietary bovine κ-caseinoglycopeptide on serum antibody levels and proliferative responses of lymphocytes in mice. Milchwissenschaft 53: 129-132.
7. Monnai, M. & Otani, H. (1997) Effect of bovine κ- caseinoglycopeptide on secretion of interleukin-1 family cytokines by P388D1 cells, a line derived from mouse monocyte/macrophage. Milchwissenschaft 52: 192-196.
8. Nakano, T., Silva-Hernandez, E. R., Ikawa, N. & Ozimek, L. (2002) Purification of kappa-casein glycomacropeptide from sweet whey with undetectable level of phenylalanine. Biotechnol. Prog. 18: 409-412.
9. Nakay, S. & Modler, H. W. (1999) Food Proteins: Processing Applications. Wiley-VCH, New York, NY.
10. Ekbom, A. (2004) The epidemiology of IBD: a lot of data but little knowledge. How shall we proceed? Inflamm. Bowel Dis. 10 (suppl. 1): S32-S34.
11. Sands, B. E. (2000) Therapy of inflammatory bowel disease. Gastroenterology 118: S68-S82.
12. Neurath, M., Fuss, I. & Strober, W. (2000) TNBS-colitis. Int. Rev. Immunol. 19: 51-62.
13. Morris, G. P., Beck, P. L., Herridge, M. S., Depew, W. T., Szewczuk, M. R. & Wallace, J. L. (1989) Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96: 795-803.
14. Bessey, O. A., Lowry, O. H. & Brook, M. J. (1946) Rapid colorimetric method for the determination of alkaline phosphatase in five cubic milliliters of serum. J. Biol. Chem. 164: 321-329.
15. Akerboom, T. P. & Sies, H. (1981) Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol. 77: 373-382.
16. Sȧnchez de Medina, F., Martínez-Augustin, O., González, R., Ballester, I., Gálvez, J. & Zarzuelo, A. (2004) Induction of alkaline phosphatase in the inflamed intestine: a novel pharmacological target for inflammatory bowel disease. Biochem. Pharmacol. 68: 2317-2326.
17. Verspaget, H. W., Aparicio-Pages, M. N., Verver, S., Edelbroek, P. M., Hafkenscheid, J. C., Crama-Bohbouth, G. E., Pena, A. S., Weterman, I. T. & Lamers, C. B. (1991) Influence of sulphasalazine and mesalazine on cellular and biochemical oxygen metabolite production. Effect of in vivo administration and an in vitro analysis. Scand. J. Gastroenterol. 26: 779-786.
18. Hibi, T., Inoue, N., Ogata, H. & Naganuma, M. (2003) Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease. J. Gastroenterol. 38 (suppl. 15): 36-42.
19. O'Sullivan, M. & O'Morain, C. (2001) Nutritional treatments in inflammatory bowel disease. Curr. Treat. Options Gastroenterol. 4: 207-213.
20. Rodriguez-Cabezas, M. E., Galvez, J., Camuesco, D., Lorente, M. D., Concha, A., Martinez-Augustin, O., Redondo, L. & Zarzuelo, A. (2003) Intestinal anti-inflammatory activity of dietary fiber (Plantago ovata seeds) in HLA-B27 transgenic rats. Clin. Nutr. 22: 463-471.
21. Kanauchi, O., Mitsuyama, K., Araki, Y. & Andoh, A. (2003) Modification of intestinal flora in the treatment of inflammatory bowel disease. Curr. Pharm. Design 9: 333-346.
22. Bassaganya-Riera, J., Reynolds, K., Martino-Catt, S., Cui, Y., Hennighausen, L., Gonzalez, F., Rohrer, J., Benninghoff, A. U. & Hontecillas, R. (2004) Activation of PPAR gamma and delta by conjugated linoleic acid mediates protection from experimental inflammatory bowel disease. Gastroenterology 127: 777-791.
23. Gil, A. (2002) Polyunsaturated fatty acids and inflammatory diseases. Biomed. Pharmacother. 56: 388-396.
24. Marteau, P., Lepage, P., Mangin, I., Suau, A., Dore, J., Pochart, P. & Seksik, P. (2004) Review article: gut flora and inflammatory bowel disease. Aliment. Pharmacol. Ther. 20 (suppl. 4): 18-23.
25. Otani, H., Horimoto, Y. & Monnai, M. (1996) Suppression of interleukin-2 receptor expression on mouse CD4+ T cells by bovine kappa-caseinoglycopeptide. Biosci. Biotechnol. Biochem. 60: 1017-1019.
26. Otani, H., Monnai, M. & Hosono, A. (1992) Bovine κ-casein as inhibitor of the proliferation of mouse splenocytes induced by lipopolysaccharide stimulation. Milchwissenschaft 47: 512-515.
27. Otani, H. & Hata, I. (1995) Inhibition of proliferative responses of mouse spleen lymphocytes and rabbit Peyer's patch cells by bovine milk caseins and their digests. J. Dairy Res. 62: 339-348.
28. Whittle, B. J., Cavicchi, M. & Lamarque, D. (2003) Assessment of anticolitic drugs in the trinitrobenzene sulfonic acid (TNBS) rat model of inflammatory bowel disease. Methods Mol. Biol. 225: 209-222.
29. Jurjus, A. R., Khoury, N. N. & Relmund, J. M. (2004) Animal models of inflammatory bowel disease. J. Pharmacol. Toxicol. Methods 50: 81-92.
30. Sanchez de Medina, F., Perez, R., Martinez-Augustin, O., Gonzalez, R., Lorente, M. D., Galvez, J. & Zarzuelo, A. (2002) Disturbances of colonic ion secretion in inflammation: role of the enteric nervous system and cAMP. Pflugers Arch. 444: 378-388.
31. Sanchez de Medina, F., Galvez, J., Romero, J. A. & Zarzuelo, A. (1996) Effect of quercitrin on acute and chronic experimental colitis in the rat. J. Pharmacol. Exp. Ther. 278: 771-779.
32. El-Haj, T., Poole, S., Farthing, M. J. & Ballinger, A. B. (2002) Anorexia in a rat model of colitis: interaction of interleukin-1 and hypothalamic serotonin. Brain Res. 927: 1-7.
33. McHugh, K. J., Collins, S. M. & Weingarten, H. P. (1994) Central interleukin-1 receptors contribute to suppression of feeding after acute colitis in the rat. Am. J. Physiol. 266: R1659-R1663.
34. Ohguchi, M., Yamato, K., Ishihara, Y., Koide, M., Ueda, N., Okahashi, N., Noguchi, T., Kizaki, M., Ikeda, Y., Sugino, H. & Nisihara, T. (1998) Activin A regulates the production of mature interleukin-1 beta and interleukin-1 receptor antagonist in human monocytic cells. J. Interferon Cytokine Res. 18: 491-498.
35. Harrison, L. M., van Haaften, W. C. & Tesh, V. L. (2004) Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1. Infect. Immun. 72: 2618-2627.
36. Hollenbach, E., Neumann, M., Vieth, M., Roessner, A., Malfertheiner, P. & Naumann, M. (2004) Inhibition of p38 MAP kinase- and RICK/NF-κB- signaling suppresses inflammatory bowel disease. FASEB J. 18: 1550-1552.
37. Renes, I. B., Verburg, M., Van Nispen, D. J., Taminiau, J. A., Buller, H. A., Dekker, J. & Einerhand, A. W. (2002) Epithelial proliferation, cell death, and gene expression in experimental colitis: alterations in carbonic anhydrase I, mucin MUC2, and trefoil factor 3 expression. Int. J. Colorectal Dis. 17: 317-326.
38. Vestergaard, E. M., Brynskov, J., Ejskjaer, K., Clausen, J. T., Thim, L., Nexo, E. & Poulsen, S. S. (2004) Immunoassays of human trefoil factors 1 and 2: measured on serum from patients with inflammatory bowel disease. Scand. J. Clin. Lab. Investig, 64: 146-156.
39. Tran, C. P., Cook, G. A., Yeomans, N. D., Thim, L. & Giraud, A. S. (1999) Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis. Gut 44: 636-642.
40. Blanchard, C., Durual, S., Estienne, M., Bouzakri, K., Heim, M. H., Blin, N. & Cuber, J. C. (2004) IL-4 and IL-13 up-regulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis. J. Immunol. 172: 3775-3783.
41. Beck, P. L. & Podolsky, D. K. (1999) Growth factors in inflammatory bowel disease. Inflamm. Bowel Dis. 5: 44-60.
42. Hasko, G., Szabo, C., Nemeth, Z. H. & Deitch, E. A. (2001) Sulphasalazine inhibits macrophage activation: inhibitory effects on inducible nitric oxide synthase expression, interleukin-12 production and major histocompatibility complex II expression. Immunology 103: 473-478.
43. Price-Schiavi, S. A., Jepson, S., Li, P., Arango, M., Rudland, P. S., Yee, L. & Carraway, K. L. (2002) Rat Muc4 (sialomucin complex) reduces binding of anti-ErbB2 antibodies to tumor cell surfaces, a potential mechanism for herceptin resistance. Int. J. Cancer 99: 783-791.
44. Pizarro, T. T., Arseneau, K. O., Bamias, G. & Cominelli, F. (2003) Mouse models for the study of Crohn's disease. Trends Mol. Med. 9: 218-222.